Skip to main content
. 2019 Apr 3;24(7):1311. doi: 10.3390/molecules24071311

Table 2.

Inhibitory effects of selected compounds against DNA gyrase and topoisomerase IV.

Compd. IC50 (µg/mL)
Gyrase a Topo IV b
4d
4k
13.5
25.7
24.2
33.1
CIP c 0.25 6.9

a Topoisomerase II supercoiling activity; b Topoisomerase IV decatenation activity. c Ciprofloxacin.